Efficacy and Safety of Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Yasser M. Saleh & Waleed Hammam · Journal of Cancer and Tumor International · 2015
Aims: Advanced Hepatocellular carcinoma (HCC) is a major health problem with limited treatment options. The Sorafenib monothearpy is the only efficacious systemic treatment agent showing a survival benefit in these patients. In our study, we evaluated the efficacy and tolerabilit...
Open access
Research Article
10.9734/JCTI/2016/22142